Perimenopause / menopause
Two evidence-backed peptide lanes (metabolic, libido); HRT owns vasomotor/bone/sleep.
Decision support, not prescription. You decide.
Monitor — GLP-1 alters oral progesterone absorption
Delayed gastric emptying changes oral progesterone (and other oral drug) absorption/timing — adjust co-prescribing.
Candidate agents
3 agents · ranked by role, then evidenceBremelanotide FDA-approved for HSDD (premenopausal RCTs); postmenopausal off-label.
PMID 31599840Monitor — GLP-1 alters oral progesterone absorption
GLP-1 addresses menopausal visceral-fat shift HRT does not; greater loss with HT.
PMID 38446869Monitor — GLP-1 alters oral progesterone absorption
6 reports · Peri weight gain + joint pain/inflammation resolved where HRT and PT failed
Matching protocol templates
Browse all →Staggered hunger control, cost reduction, side effect modulation
Libido enhancement and erectile support
Enhance sexual desire and response in men or women
The platform surfaces evidence, community signal and peer outcomes with enforced cautions. It never decides treatment — the licensed clinician orders labs, writes notes, and prescribes.